SCHEMBL14354517

SCHEMBL14354517

CC(F)(F)c1cccc(C(=O)O)n1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.57
ALOX15 P16050 1/20 0.57
TSHR P16473 1/20 0.57
ACMSD Q8TDX5 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
P2RX7 Q99572 1/20 0.47
LMNA P02545 2/20 0.46
ECE1 P42892 1/20 0.41
GNE Q9Y223 1/20 0.41
MMP2 P08253 1/20 0.40
KMT2A Q03164 1/20 0.40
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
AHR P35869 1/20 0.39
MGAM O43451 1/20 0.39
PGK1 P00558 1/20 0.39
PGK2 P07205 1/20 0.39
CBLB Q13191 1/20 0.38
NAPRT Q6XQN6 1/20 0.38
P4HTM Q9NXG6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29381032 1.00 KDM4E (0.57) KDM4EALOX15TSHRACMSDTDP1
SCHEMBL22835203 0.89 KDM4E (0.57) KDM4EALOX15TSHRACMSDTDP1
SCHEMBL496206 0.85 P2RX7 (0.64) KDM4EALOX15TSHRACMSDTDP1
SCHEMBL17489112 0.85 KDM4E (0.61) KDM4EALOX15TSHRACMSDTDP1
SCHEMBL2627808 0.85 KDM4E (0.61) KDM4EALOX15TSHRACMSDTDP1
SCHEMBL29375278 0.85 P2RX7 (0.64) KDM4EALOX15TSHRACMSDTDP1
SCHEMBL22836048 0.84 P2RX7 (0.50) KDM4EALOX15TSHRACMSDTDP1
SCHEMBL22836421 0.84 P2RX7 (0.46) KDM4EALOX15TSHRACMSDTDP1
SCHEMBL29502443 0.84 P2RX7 (0.50) KDM4EALOX15TSHRACMSDTDP1
Hydrochloric Acid SCHEMBL3743949 0.83 KDM4E (0.59) KDM4EALOX15TSHRACMSDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720058-A2 BIFUNCTIONAL DEGRADERS AND USES THEREOF Casma Therapeutics, Inc. (US) 2026-04-08 EP disclosed
US-20260042749-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2026-02-12 US disclosed
US-12545659-B2 IRAK degraders and uses thereof KYMERA THERAPEUTICS, INC. (US) 2026-02-10 US disclosed
US-12539295-B2 IRAK degraders and uses thereof KYMERA THERAPEUTICS, INC. (US) 2026-02-03 US disclosed
US-20250333417-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS INC (US) 2025-10-30 US disclosed
US-20250121073-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2025-04-17 US disclosed
WO-2024249291-A2 BIFUNCTIONAL DEGRADERS AND USES THEREOF CASMA THERAPEUTICS, INC. (US) 2024-12-05 WO disclosed
US-12150995-B2 IRAK degraders and uses thereof KYMERA THERAPEUTICS, INC. (US) 2024-11-26 US disclosed
US-20240131016-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2024-04-25 US disclosed
US-20240059674-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2024-02-22 US disclosed
WO-2020264499-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2020-12-30 WO disclosed
WO-2020264499-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2020-12-30 WO disclosed
EP-2725903-B1 3-ALKOXY, THIOALKYL AND AMINO-4-AMINO-6-(SUBSTITUTED)PICOLINATES AND THEIR USE AS HERBICIDES DOW AGROSCIENCES LLC (US) 2020-04-15 EP disclosed
WO-2018060072-A1 NEW SUBSTITUTED BENZIMIDAZOLES, METHODS FOR THE PRODUCTION OF SAME, PHARMACEUTICAL PREPARATIONS CONTAINING SAME, AND USE OF SAME TO PRODUCE DRUGS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-04-05 WO disclosed
US-9518018-B2 3-alkoxy, thioalkyl and amino-4-amino-6-(substituted)picolinates and their use as herbicides DOW AGROSCIENCES LLC (US) 2016-12-13 US disclosed
US-20150133301-A1 3-ALKOXY, THIOALKYL AND AMINO-4-AMINO-6-(SUBSTITUTED)PICOLINATES AND THEIR USE AS HERBICIDES DOW AGROSCIENCES LLC (US) 2015-05-14 US disclosed
US-8754229-B2 3-alkoxy, thioalkyl and amino-4-amino-6-(substituted)picolinates and their use as herbicides DOW AGROSCIENCES, LLC. (US) 2014-06-17 US disclosed
EP-2725903-A1 3-ALKOXY, THIOALKYL AND AMINO-4-AMINO-6-(SUBSTITUTED)PICOLINATES AND THEIR USE AS HERBICIDES Dow AgroSciences LLC (US) 2014-05-07 EP disclosed
US-20130005574-A1 3-ALKOXY, THIOALKYL AND AMINO-4-AMINO-6-(SUBSTITUTED)PICOLINATES AND THEIR USE AS HERBICIDES CORTEVA AGRISCIENCE LLC 2013-01-03 US disclosed
WO-2013003740-A1 3-ALKOXY, THIOALKYL AND AMINO-4-AMINO-6-(SUBSTITUTED)PICOLINATES AND THEIR USE AS HERBICIDES DOW AGROSCIENCES LLC (US) 2013-01-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12545659-B2 IRAK degraders and uses thereof IRAK2, IRAK3, IRAK4 KDM4E 240/4885ALOX15 3869/4885TSHR 629/4885
US-20130005574-A1 3-ALKOXY, THIOALKYL AND AMINO-4-AMINO-6-(SUBSTITUTED)PICOLINATES AND THEIR USE AS HERBICIDES DDT, AADAC, AADAT KDM4E 1083/4885ALOX15 2247/4885TSHR 489/4885
US-20250121073-A1 IRAK DEGRADERS AND USES THEREOF IRAK2, IRAK3, IRAK1 KDM4E 190/4885ALOX15 3105/4885TSHR 3319/4885
US-12539295-B2 IRAK degraders and uses thereof IRAK2, IRAK4, IRAK3 KDM4E 810/4885ALOX15 2544/4885TSHR 357/4885
US-20240131016-A1 IRAK DEGRADERS AND USES THEREOF IRAK2, IRAK3, IRAK1 KDM4E 190/4885ALOX15 3105/4885TSHR 3319/4885
US-20150133301-A1 3-ALKOXY, THIOALKYL AND AMINO-4-AMINO-6-(SUBSTITUTED)PICOLINATES AND THEIR USE AS HERBICIDES DDT, AADAC, AADAT KDM4E 1083/4885ALOX15 2247/4885TSHR 489/4885
US-12150995-B2 IRAK degraders and uses thereof IRAK2, IRAK3, IRAK1 KDM4E 190/4885ALOX15 3105/4885TSHR 3319/4885
US-20260042749-A1 IRAK DEGRADERS AND USES THEREOF IRAK2, IRAK3, IRAK4 KDM4E 628/4885ALOX15 3935/4885TSHR 334/4885
US-20240059674-A1 IRAK DEGRADERS AND USES THEREOF IRAK2, IRAK3, IRAK1 KDM4E 190/4885ALOX15 3105/4885TSHR 3319/4885
US-20250333417-A1 IRAK DEGRADERS AND USES THEREOF IRAK2, IRAK3, IRAK1 KDM4E 190/4885ALOX15 3105/4885TSHR 3319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.